Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Metacrine, Inc. (MTCR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/24/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/24/2023 |
4
| Klassen Preston (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 842,211 shares
@ $0.47, valued at
$395.8k
Disposed/sold 842,211 options to buy
@ $0.47, valued at
$395.8k
|
|
| 03/23/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/23/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets Interactive Data |
| 03/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/03/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 02/14/2023 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 10% stake in Metacrine, Inc. |
| 02/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an... |
| 02/08/2023 |
SC 13G/A
| BML Investment Partners, L.P. reports a 15.9% stake in Metacrine, Inc. |
| 02/03/2023 |
8-K
| Quarterly results |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/27/2023 |
4
| York Michael (Chief Business Officer) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 107,054 shares
@ $0.4141, valued at
$44.3k
|
|
| 01/27/2023 |
4
| Klassen Preston (President & CEO) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Sold 380,605 shares
@ $0.4132, valued at
$157.3k
|
|
| 01/24/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 01/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/21/2022 |
4
| Leonard Braden Michael (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Bought 101,384 shares
@ $0.4, valued at
$40.6k
Bought 50,122 shares
@ $0.3791, valued at
$19k
Bought 120,099 shares
@ $0.4, valued at
$48k
|
|
| 12/19/2022 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 7.1% stake in Metacrine, Inc. |
| 12/14/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/08/2022 |
SC 13D
| BML Investment Partners, L.P. reports a 15.2% stake in Metacrine, Inc. |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/11/2022 |
8-K
| Other Events Interactive Data |
| 09/28/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/27/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/26/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/07/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/06/2022 |
4
| Nashat Amir (10% Owner) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| JONKER JEFFREY DAVID (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| McHutchison John G (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| Owens Julia C. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 09/06/2022 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
|
|
|